MEDTOX Scientific Inc (MTOX.OQ)
MTOX.OQ on NASDAQ Stock Exchange Global Select Market
26.90USD
4:00pm EDT
26.90USD
4:00pm EDT
Price Change (% chg)
$0.05 (+0.19%)
$0.05 (+0.19%)
Prev Close
$26.85
$26.85
Open
$26.85
$26.85
Day's High
$26.90
$26.90
Day's Low
$26.85
$26.85
Volume
7,739
7,739
Avg. Vol
123,706
123,706
52-wk High
$26.94
$26.94
52-wk Low
$11.64
$11.64
About
MEDTOX Scientific, Inc. (MEDTOX) operates through its wholly owned subsidiaries, MEDTOX Laboratories, Inc. (MEDTOX Laboratories), MEDTOX Diagnostics, Inc. (MEDTOX Diagnostics) and New Brighton Business Center, LLC (NBBC). MEDTOX Laboratories provides forensic and clinical laboratory services. MEDTOX Diagnostics manufactures and... (more)
Overall
Beta: | 1.00 |
Market Cap (Mil.): | $240.85 |
Shares Outstanding (Mil.): | 8.97 |
Dividend: | 1.25 |
Yield (%): | -- |
Financials
MTOX.OQ | Industry | Sector | |
---|---|---|---|
P/E (TTM): | 47.00 | 20.39 | 43.38 |
EPS (TTM): | 0.57 | -- | -- |
ROI: | 8.13 | 3.37 | 9.53 |
ROE: | 9.17 | 5.47 | 11.11 |
LabCorp to buy rival Medtox for $245 million
- Lab-testing company Laboratory Corp of America Holdings will buy smaller rival Medtox Scientific Inc for $27 a share, or about $245 million, in cash.
UPDATE 1-LabCorp to buy rival Medtox for $245 mln
June 4 - Lab-testing company Laboratory Corp of America Holdings will buy smaller rival Medtox Scientific Inc for $27 a share, or about $245 million, in cash.
UPDATE 1-Medtox Scientific's 1st-qtr beats expectations
April 12 - Medtox Scientific Inc posted quarterly results that beat market expectations, helped by strong revenue in its clinical laboratory segment, sending its shares up to a year high.
Competitors
Price | Change | |
---|---|---|
Quest Diagnostics Inc (DGX.N) | $57.65 | +0.58 |
Laboratory Corp. of America Holdings (LH.N) | $89.37 | +0.25 |
American Bio Medica Corporation (ABMC.PK) | $0.17 | +0.00 |
Alere Inc (ALR.N) | $18.34 | +0.44 |
Alere Inc (ALR_pb.N) | $203.60 | +0.18 |
Earnings vs Estimates
Analyst Research Reports
Report Title | Price |
---|---|
Provider: Thomson Reuters Stock Report
|
$25.00
|
Provider: Plunkett Research, Ltd.
|
$49.00
|
Provider: ValuEngine, Inc.
|
$127.00
|
Provider: Reuters Investment Profile
|
$20.00
|
Provider: Validea
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.